Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K201051
    Date Cleared
    2020-09-24

    (156 days)

    Product Code
    Regulation Number
    872.3930
    Panel
    Dental
    Reference & Predicate Devices
    Why did this record match?
    Device Name :

    Straumann BoneCeramic

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    Straumann® BoneCeramic is indicated for filling and/or augmenting the following intraoral/maxillofacial osseous defects:

    • Intrabony periodontal osseous and furcation defects
    • Augmentation of bony defects of the alveolar ridge ●
    • Filling tooth extraction sites ●
    • Sinus elevation grafting .
    Device Description

    Straumann® BoneCeramic is a fully synthetic bone graft substitute of medical grade purity in particulate form composed of biphasic calcium phosphate. It consists of a mixture of 60% hydroxyapatite (HA), which is 100% crystalline, and of 40% of the beta form of tricalcium phosphate (beta-TCP). BoneCeramic is 90% porous with interconnected pores of 100-500 microns in diameter. It is osteoconductive and gradually resorbed and replaced by vital bone during bone remodeling.
    BoneCeramic is available in two granule sizes: 400-700 µm diameter and 500-1000 µm diameter and in three different filling volumes: 0.25g, 0.5g and 1.0g. It is delivered sterile.

    AI/ML Overview

    This document is an FDA 510(k) summary for the Straumann® BoneCeramic device. It primarily focuses on demonstrating substantial equivalence to a predicate device rather than presenting a study to prove performance against specific acceptance criteria for a novel device. Therefore, many of the requested elements are not applicable in the context of this 510(k) summary.

    However, based on the provided text, here’s an analysis:

    1. A table of acceptance criteria and the reported device performance

    The document does not present specific acceptance criteria in a quantitative table format with corresponding device performance metrics for a clinical study. Instead, it relies on demonstrating substantial equivalence to a legally marketed predicate device (K040646 Straumann Granules) by showing similar technological characteristics and relying on the predicate's established safety and effectiveness.

    The "reported device performance" is primarily qualitative and inferred from the long-term use of the predicate device and the new device sharing similar characteristics.

    Acceptance Criteria (Implied)Reported Device Performance
    Biocompatibility: Meet ISO 10993 standards and FDA guidance.Biocompatibility confirmed. (Evaluated for the new packaging material)
    Packaging Validation: Meet ISO 11607 and ASTM F1980.Packaging process and shelf life validated.
    Sterilization Validation: Meet ISO 11137.Sterilization process validated according to ISO 11137.
    Pyrogenicity: LAL Endotoxin Analysis
    Ask a Question

    Ask a specific question about this device

    Page 1 of 1